3/18
08:07 am
sxtp
60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (NDIN) with FDA for Australian Chestnut Extract [Yahoo! Finance]
Medium
Report
60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (NDIN) with FDA for Australian Chestnut Extract [Yahoo! Finance]
3/18
08:01 am
sxtp
60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (NDIN) with FDA for Australian Chestnut Extract
High
Report
60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (NDIN) with FDA for Australian Chestnut Extract
3/11
08:04 am
sxtp
60 Degrees Pharmaceuticals Announces All Patients Cured of Babesiosis After Tafenoquine Treatment in Expanded Use Clinical Trial [Yahoo! Finance]
High
Report
60 Degrees Pharmaceuticals Announces All Patients Cured of Babesiosis After Tafenoquine Treatment in Expanded Use Clinical Trial [Yahoo! Finance]
3/11
07:24 am
sxtp
60 Degrees Pharmaceuticals Announces All Patients Cured of Babesiosis After Tafenoquine Treatment in Expanded Use Clinical Trial
High
Report
60 Degrees Pharmaceuticals Announces All Patients Cured of Babesiosis After Tafenoquine Treatment in Expanded Use Clinical Trial
2/27
07:03 pm
sxtp
60 Degrees Pharmaceuticals and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV [Yahoo! Finance]
Medium
Report
60 Degrees Pharmaceuticals and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV [Yahoo! Finance]
2/24
01:29 pm
sxtp
60 Degrees Pharmaceuticals (SXTP) Partners With GoodRx to Expand Access to ARAKODA [Yahoo! Finance]
Low
Report
60 Degrees Pharmaceuticals (SXTP) Partners With GoodRx to Expand Access to ARAKODA [Yahoo! Finance]
2/2
08:13 am
sxtp
60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx Partnership [Yahoo! Finance]
Medium
Report
60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx Partnership [Yahoo! Finance]
2/2
08:01 am
sxtp
60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx Partnership
High
Report
60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx Partnership
1/28
08:01 am
sxtp
60 Degrees Pharmaceuticals Exercises License Option with Florida State University for Large-Scale Purification of Castanospermine for Non-Rx Use
Medium
Report
60 Degrees Pharmaceuticals Exercises License Option with Florida State University for Large-Scale Purification of Castanospermine for Non-Rx Use
1/27
11:45 am
sxtp
60 Degrees Pharmaceuticals (NASDAQ:SXTP) had its price target raised by analysts at HC Wainwright from $6.00 to $24.00. They now have a "buy" rating on the stock.
Medium
Report
60 Degrees Pharmaceuticals (NASDAQ:SXTP) had its price target raised by analysts at HC Wainwright from $6.00 to $24.00. They now have a "buy" rating on the stock.
1/15
08:25 am
sxtp
60 Degrees Pharma announces 1-for-4 reverse stock split; shares up [Seeking Alpha]
Medium
Report
60 Degrees Pharma announces 1-for-4 reverse stock split; shares up [Seeking Alpha]
1/15
08:01 am
sxtp
60 Degrees Pharmaceuticals, Inc. Announces Approval of Reverse Stock Split Ratio
High
Report
60 Degrees Pharmaceuticals, Inc. Announces Approval of Reverse Stock Split Ratio
12/30
04:09 pm
sxtp
60 Degrees Pharmaceuticals (NASDAQ:SXTP) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
60 Degrees Pharmaceuticals (NASDAQ:SXTP) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
12/29
08:48 am
sxtp
60 Degrees Pharmaceuticals Announces Detection of Babesia Infection in 24 Percent of Patients Presenting with Chronic Fatigue in Peer-Reviewed, Sponsored Study at NC State [Yahoo! Finance]
High
Report
60 Degrees Pharmaceuticals Announces Detection of Babesia Infection in 24 Percent of Patients Presenting with Chronic Fatigue in Peer-Reviewed, Sponsored Study at NC State [Yahoo! Finance]
12/29
08:01 am
sxtp
60 Degrees Pharmaceuticals Announces Detection of Babesia Infection in 24 Percent of Patients Presenting with Chronic Fatigue in Peer-Reviewed, Sponsored Study at NC State
High
Report
60 Degrees Pharmaceuticals Announces Detection of Babesia Infection in 24 Percent of Patients Presenting with Chronic Fatigue in Peer-Reviewed, Sponsored Study at NC State
12/23
04:09 pm
sxtp
60 Degrees Pharmaceuticals (NASDAQ:SXTP) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
60 Degrees Pharmaceuticals (NASDAQ:SXTP) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.